These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8582533)
1. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM. Routsias J; Papadopoulos GK Diabetologia; 1995 Nov; 38(11):1251-61. PubMed ID: 8582533 [TBL] [Abstract][Full Text] [Related]
2. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR. Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340 [TBL] [Abstract][Full Text] [Related]
4. The combination of several polymorphic amino acid residues in the DQalpha and DQbeta chains forms a domain structure pattern and is associated with insulin-dependent diabetes mellitus. Sanjeevi CB; Landin-Olsson M; Kockum I; Dahlquist G; Lernmark A Ann N Y Acad Sci; 2002 Apr; 958():362-75. PubMed ID: 12021143 [TBL] [Abstract][Full Text] [Related]
5. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes. Parry CS; Brooks BR Biol Direct; 2008 Oct; 3():42. PubMed ID: 18854049 [TBL] [Abstract][Full Text] [Related]
6. Improved risk assessment for insulin-dependent diabetes mellitus by analysis of amino acids in HLA-DQ and DRB1 loci. Zamani Ghabanbasani M; Spaepen M; Buyse I; Marynen P; Bex M; Bouillon R; Cassiman JJ Eur J Hum Genet; 1994; 2(3):177-84. PubMed ID: 7834277 [TBL] [Abstract][Full Text] [Related]
7. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Hoover ML; Marta RT Scand J Immunol; 1997 Feb; 45(2):193-202. PubMed ID: 9042432 [TBL] [Abstract][Full Text] [Related]
8. HLA DQA1 genotypes and its interaction with HLA DQB1 in Chinese IDDM living in Taiwan. Chuang LM; Jou TS; Wu HP; Chang HM; Tsai WY; Hsieh RP; Chen KH; Lin BJ; Tai TY Proc Natl Sci Counc Repub China B; 1995 Apr; 19(2):73-9. PubMed ID: 7624445 [TBL] [Abstract][Full Text] [Related]
9. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. Ettinger RA; Liu AW; Nepom GT; Kwok WW J Immunol; 2000 Sep; 165(6):3232-8. PubMed ID: 10975839 [TBL] [Abstract][Full Text] [Related]
10. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. Baisch JM; Weeks T; Giles R; Hoover M; Stastny P; Capra JD N Engl J Med; 1990 Jun; 322(26):1836-41. PubMed ID: 2348836 [TBL] [Abstract][Full Text] [Related]
11. HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland. Reijonen H; Ilonen J; Knip M; Akerblom HK Diabetes; 1991 Dec; 40(12):1640-4. PubMed ID: 1756904 [TBL] [Abstract][Full Text] [Related]
12. HLA DQ alpha/beta molecule associated with the susceptibility to insulin-dependent diabetes mellitus. A model for HLA/autoimmune disease association. Khalil I; Deschamps I; Lepage V; Morin L; Galibert F; Degos L; Hors J Nouv Rev Fr Hematol (1978); 1990; 32(6):445-7. PubMed ID: 2101877 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM. Tosi G; Facchin A; Pinelli L; Accolla RS Diabetes Care; 1994 Sep; 17(9):1045-9. PubMed ID: 7988304 [TBL] [Abstract][Full Text] [Related]
14. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974 [TBL] [Abstract][Full Text] [Related]
15. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells. Moustakas AK; Papadopoulos GK Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175 [TBL] [Abstract][Full Text] [Related]
17. HLA-DQ beta typing and non-Asp57 alleles in IDDM and nondiabetic subjects in New Zealand. Forbes LV; Brown LJ; Scott RS Diabetes Care; 1993 Aug; 16(8):1179-83. PubMed ID: 8104110 [TBL] [Abstract][Full Text] [Related]
18. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. Khalil I; d'Auriol L; Gobet M; Morin L; Lepage V; Deschamps I; Park MS; Degos L; Galibert F; Hors J J Clin Invest; 1990 Apr; 85(4):1315-9. PubMed ID: 2318983 [TBL] [Abstract][Full Text] [Related]
19. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048 [TBL] [Abstract][Full Text] [Related]